You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
7 April 2026 - US biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Tuesday that it has entered into a definitive agreement to acquire Tubulis GmbH, a German clinical-stage biotechnology company focused on next-generation antib...
7 April 2026 - Biotechnology ecosystem company Alloy Therapeutics announced on Tuesday that it has entered into a multi-target collaboration and licence agreement with biotechnology company Biogen Inc (Nasdaq:BIIB) to advance antisense therapeutics u...
7 April 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Tuesday that its investigational candidate lunsekimig met primary and key secondary endpoints in phase 2 studies in asthma and chronic rhinosinusitis w...
7 April 2026 - Chinese biopharmaceutical company Akeso Inc (HK:9926) said on Monday that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated results with a median follow-up of 21.45 months from a prospective, open-label, singl...
2 April 2026 - Caliway Biopharmaceuticals (TWSE:6919), a Taiwan-based clinical-stage biopharmaceutical company, announced on Thursday that the latest preclinical data on its first-in-class large-area localised fat reduction drug candidate, CBL-514, i...